Filing Details
- Accession Number:
- 0001127602-14-030239
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2014-10-23 20:49:30
- Reporting Period:
- 2014-10-16
- Filing Date:
- 2014-10-23
- Accepted Time:
- 2014-10-23 20:49:30
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1082554 | United Therapeutics Corp | UTHR | Pharmaceutical Preparations (2834) | 521984749 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1231589 | A Paul Mahon | C/O United Therapeutics Corporation 1040 Spring Street Silver Spring MD 20910 | Evp & General Counsel | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2014-10-16 | 6,000 | $33.14 | 40,832 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2014-10-16 | 6,000 | $124.38 | 34,832 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2014-10-23 | 5,000 | $30.75 | 39,832 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2014-10-23 | 1,158 | $129.29 | 38,674 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2014-10-23 | 2,566 | $130.20 | 36,108 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2014-10-23 | 1,276 | $131.16 | 34,832 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Share Tracking Award | Disposition | 2014-10-16 | 6,000 | $0.00 | 6,000 | $33.14 |
| Common Stock | Stock Options | Disposition | 2014-10-23 | 5,000 | $0.00 | 5,000 | $30.75 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 94,750 | 2010-03-13 | 2019-03-13 | No | 4 | M | Direct |
| 19,750 | 2009-09-14 | 2017-09-14 | No | 4 | M | Direct |
Footnotes
- Exercise of a cash-settled share tracking award pursuant to a Rule 10b5-1 trading plan entered into by the reporting person.
- Exercise price and number of shares/awards has been adjusted to reflect the issuer's two-for-one stock split on September 22, 2009.
- This exercise of stock options and corresponding sale of shares was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person.
- This transaction was executed in multiple trades at prices ranging from $128.74 to $129.70. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- This transaction was executed in multiple trades at prices ranging from $129.81 to $130.78. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- This transaction was executed in multiple trades at prices ranging from $130.81 to $131.62. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Billionaire Hedge Funds
